Sinofn Health
Sinofn Health
Coenzyme Q10 (CoQ10) remains a cornerstone of the global nutraceutical market. As a professional ODM partner, SINOFN understands the critical distinction between its two primary forms: Ubiquinone and Ubiquinol. For brands entering the competitive cardiovascular and anti-aging supplement space, understanding the manufacturing nuances of these molecules is the key to product differentiation.
Ubiquinone is the oxidized, stable form of CoQ10. It is the industry standard for cost-effective, long-shelf-life formulations. It is excellent for younger demographics or general wellness maintenance.
Ubiquinol, the reduced form, acts as a potent antioxidant. It is significantly more bioavailable, particularly for older adults whose bodies struggle to convert Ubiquinone into the active form. Manufacturing Ubiquinol is highly complex—it is oxygen-sensitive, requiring advanced encapsulation technologies to prevent premature oxidation. At SINOFN, our R&D focus is on stabilizing Ubiquinol to ensure maximum potency until the expiration date.
The global demand for high-quality CoQ10 is surging. Manufacturers in China, particularly high-tech enterprises like SINOFN, have optimized production through:
Our ODM services cater to various regional application scenarios:
SINOFN Health Co., Ltd. (Est. 2025) operates as the trading hub of the SINOFN Group, a national high-tech enterprise founded in 2012. Our roots in the Chinese Academy of Sciences provide us with an unparalleled depth of scientific authority.
Born from a clinical mission to help children with PKU, our company culture prioritizes "Profit with Purpose." This ethical foundation ensures that every product, whether it is high-end CoQ10 or specialized nutritional food, is developed with rigorous quality controls and a commitment to health outcomes.
Our team is headed by experts from the Chinese Academy of Sciences and Peking University Medical School. We emphasize the science behind the supplement, ensuring that when you choose our ODM/OEM services, you are gaining access to research-backed formulations (e.g., Dr. Tan Shengjie, Director of Medical Innovation; Hans van Dijk, Senior Scientist).
A: Yes. We operate a pilot-scale prototyping facility where we test bioavailability and stability before full-scale production. Whether you need a specific dosage of Ubiquinol or a multi-ingredient blend, our lab supports the R&D process.
A: We serve global markets with full certification support, including ISO22000, HACCP, and HALAL. Our facilities are designed to meet diverse regulatory environments, from the FDA to EFSA standards.
A: Beyond cost-efficiency, the primary advantage is technological capability. Chinese manufacturing hubs are now leading the world in advanced delivery systems like enteric-coated softgels and micro-encapsulation, which are crucial for the stability of sensitive compounds like CoQ10.
